Team In Training Information Meetings – In the coming weeks, the Leukemia & Lymphoma Society’s Team In Training (TNT) is going to hold informational meetings across the country. These meetings allow those interested to learn more about the TNT and to register for future events. To locate a meeting near you, please visit the TNT Web site and enter your zip code.

Senesco Technologies Enters Agreement For $1 Million in Proceeds – On July 9, Senesco Technologies announced its purchase agreement with Partlet Holdings. Senesco, a biotechnology company in New Jersey, plans to use the money from proceeds to further develop its research in multiple myeloma. The anticipated $1 million funding will help fulfill Senesco’s goal of initiating a Phase 1 clinical trial for SNS01-T, a potential myeloma drug candidate. For more information, please see the Senesco Web site.

The IMF Joins Together With the Associazione Schirinzi A. Mario – The International Myeloma Foundation (IMF) announced their new alliance with Associazione Schirinzi A. Mario, an association created to educate people in Italy by providing the latest news on multiple myeloma. The two organizations will share their resources to continue their fight against multiple myeloma and better serve the people in Italy who are affected by myeloma. For more information, please see the article on the IMF Web site or visit the Associazione Schirinzi A. Mario Web site (in Italian).

For a more detailed listing of myeloma related events, please check the Myeloma Beacon Events Calendar.